
To help keep our community authentic, we're showing information about accounts on Linktree.
@IgG4EU has been a member of Linktree for 2 months and joined in May 2026. The social media accounts linked to from @IgG4EU are: • Facebook • Instagram • LinkedIn Besides social media accounts, EFigg4 has populated their site with: • Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine | Tue, 06/02 • Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy • Clinical Research Studies | Sanofi Studies • RILIEF, a clinical trial for IgG4-Related Disease • AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026| Amgen • Discover Our Mission • Start a National Association • Join the Federation • Support us